Caleres (CAL) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
9 Sep, 2026Executive summary
Second quarter net sales rose 5.6% year-over-year to $695 million, with adjusted EPS of $0.47, exceeding expectations and consensus, driven by strong Brand Portfolio growth and international momentum, while Famous Footwear sales declined.
Brand Portfolio sales surged 23.6% (8.2% organically), with notable market share gains in women's fashion footwear and international sales up 57%.
Gross margin expanded 1,140 basis points to 54.8% due to tariff refunds; adjusted gross margin rose 340 basis points to 46.8%.
GAAP EPS was $1.71, up from $0.20 last year; adjusted EPS was $0.47, up from $0.35.
Market share gains were noted in total footwear and women's fashion footwear.
Financial highlights
Second quarter sales were $695 million, up 5.6% year-over-year; trailing twelve-month revenue was $2.85 billion, with 71% from direct-to-consumer channels.
Brand Portfolio organic sales increased 8.2%; including Stuart Weitzman, up 23.6%.
Famous Footwear sales down 6.3% with comparable sales down 5.9%; premium product sales at Famous Footwear increased 21.7%.
Consolidated adjusted gross margin was 46.8%, up 340 bps; Brand Portfolio gross margin 49.1%, up 880 bps; Famous Footwear gross margin 42.7%, down 100 bps.
Operating earnings were $22.1 million (3.2% margin); adjusted net earnings were $16.1 million, up from $11.7 million.
Outlook and guidance
Raised lower end of adjusted EPS guidance for the year to $1.50–$1.65; full-year GAAP EPS expected at $2.80–$2.95.
Expecting consolidated sales up low to mid single digits for FY2026; Brand Portfolio up low double digits, Famous Footwear down low to mid single digits.
Q3 2026 net sales expected to rise low single digits; GAAP EPS guidance: $0.62–$0.70; gross margin to improve 150–200 bps.
Full-year gross margin to improve 180–220 bps; capital expenditures $50–$55 million.
Latest events from Caleres
- Brand Portfolio drove 8.5% sales growth and margin gains, offsetting Famous Footwear declines.CAL
Q1 2027 - Director elections, auditor ratification, and compensation plan up for vote at annual meeting.CAL
Proxy filing - Shareholders will vote on directors, auditor, compensation plan, and executive pay amid strategic growth.CAL
Proxy filing - Q4 and FY25 beat guidance as e-commerce and Brand Portfolio drive margin and earnings recovery.CAL
Q4 2026 - Sales up 6.6% with strong brands, but margins and EPS pressured by tariffs and integration.CAL
Q3 2026 - Disciplined management, strong brands, and robust governance position the company for future growth.CAL
Proxy Filing - Q3 sales fell 2.8% to $740.9M as margin pressure and inventory actions led to reduced guidance.CAL
Q3 2025 - Sales down 1.8% as ERP disruptions and weak demand led to lower results and revised guidance.CAL
Q2 2025 - FY24 met guidance; FY25 outlook cautious with Stuart Weitzman acquisition and sourcing shift.CAL
Q4 2025